Magnesium Supplements for High Blood Pressure
Palo Alto (17 mi)Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: Brigham and Women's Hospital
Trial Summary
What is the purpose of this trial?This double-blind, placebo-controlled randomized clinical trial will test whether a magnesium glycinate supplement (480 mg/day) taken for 12 weeks lowers blood pressure.
Eligibility Criteria
This trial is for adults with high blood pressure (systolic 120-149 mmHg or diastolic 80-94 mmHg) who are willing to keep their diet and supplement intake the same during the study. They must have a BMI under 35, not take more than 100 mg/day of magnesium supplements, and cannot be planning to move out of Boston within a year.Inclusion Criteria
I take 100 mg or less of magnesium supplements daily.
Exclusion Criteria
I cannot or will not take 4 pills daily.
I have a history of diabetes (type 1 or 2).
I have not had any cancer, except for non-melanoma skin cancer, in the last 5 years.
I have a history of inflammatory bowel disease.
I have a history of kidney disease.
I am not pregnant, nursing, or planning to become pregnant during treatment.
I have had kidney failure in the past.
I have a history of heart disease, including heart attack, stroke, or procedures to improve blood flow to my heart.
I have had pancreatitis before.
I am unable to sign a consent form.
I have been on dialysis.
Treatment Details
The trial is testing if taking magnesium glycinate (480 mg/day) for three months can lower blood pressure. Participants will either receive this supplement or a placebo without knowing which one they're getting.
2Treatment groups
Active Control
Placebo Group
Group I: magnesiumActive Control1 Intervention
magnesium glycinate supplement, 480 mg/day
Group II: placeboPlacebo Group1 Intervention
placebo supplement
Magnesium Glycinate Supplement is already approved in United States, Canada, European Union for the following indications:
πΊπΈ Approved in United States as Magnesium Glycinate for:
- Dietary Supplementation
π¨π¦ Approved in Canada as Magnesium Glycinate for:
- Dietary Supplementation
πͺπΊ Approved in European Union as Magnesium Glycinate for:
- Dietary Supplementation
Find a clinic near you
Research locations nearbySelect from list below to view details:
Brigham and Women's HospitalBoston, MA
Loading ...
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
Pure EncapsulationsIndustry Sponsor